PubMed HealthSearch

Biomedical subjects

Yanbing Wang

Publications and source records attributed to Yanbing Wang.

2 recordsLinked to original sources

Rapid transcriptional reprogramming underlies Fusarium wilt resistance in strawberry: insights from comparative physiological and transcriptomic analyses.

INTRODUCTION: Fusarium wilt caused by Fusarium oxysporum f. sp. fragariae (Fof) severely constrains strawberry production, yet the underlying resistance mechanisms remain unclear. METHODS: A total of 64 strawberry germplasm accessions were evaluated for Fusarium wilt resistance. Integrated physiological and transcriptomic analyses were subsequently performed using the highly resistant cultivar 'Akihime' (ZJ) and the highly susceptible cultivar 'Ning Yu' (NY). RESULTS: Resistant resources were abundant, particularly among wild strawberry accessions. Compared with NY, ZJ exhibited higher soluble sugar accumulation, reduced oxidative damage, and increased peroxidase (POD) and phenylalanine ammonia-lyase (PAL) activities. Transcriptomic analyses revealed distinct temporal response patterns: ZJ underwent rapid and extensive transcriptional reprogramming at 24 h post-inoculation, whereas NY showed limited early responses but pronounced changes at 120 h. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses indicated that the early response of ZJ was mainly associated with stress-related processes, jasmonic acid-mediated signaling, transmembrane transport, plant-pathogen interaction, mitogen-activated protein kinase (MAPK) signaling, glutathione metabolism, plant hormone signal transduction, and secondary metabolism. Quantitative real-time polymerase chain reaction (qRT-PCR) validation supported the RNA-seq results and identified candidate genes associated with pathogen recognition, signaling, redox regulation, and protein homeostasis. DISCUSSION: These results indicate that rapid early immune activation and coordinated physiological and metabolic reprogramming are closely associated with strawberry resistance to Fof and provide useful germplasm and candidate genes for future functional validation and resistance breeding.

Fusarium oxysporum f. sp. fragariae

Frequency of variants in Mendelian Alzheimer's disease genes within the Alzheimer's Disease Sequencing Project.

BackgroundPrior studies examined variants within presenilin-2 (PSEN2), presenilin-1 (PSEN1), and amyloid precursor protein (APP) genes. However, previously-reported clinically-relevant variants and other predicted damaging missense (DM) variants have not been characterized in a newer release of the Alzheimer's Disease Sequencing Project (ADSP).ObjectiveTo characterize previously-reported clinically-relevant variants and DM variants in PSEN2, PSEN1, APP within the participants from the ADSP.MethodsWe identified rare variants (MAF&#x2009;<&#x2009;1%) in PSEN2, PSEN1, and APP in 14,641 individuals with whole genome sequencing and 16,849 individuals with whole exome sequencing available (Ntotal&#x2009;=&#x2009;31,490). We additionally curated variants from ClinVar, OMIM, and Alzforum and report carriers of variants in clinical databases as well as predicted DM variants in these genes.ResultsWe detected 31 previously-reported clinically-relevant variants with alternate alleles observed within the ADSP: 4 variants in PSEN2, 25 in PSEN1, and 2 in APP. The overall variant carrier rate for the 31 clinically-relevant variants in the ADSP was 0.3%. We observed that 79.5% of the variant carriers were cases compared to 3.9% were controls. In those with AD, the mean age of onset of AD among carriers of these clinically-relevant variants was 19.6&#x2009;&#xb1;&#x2009;1.4 years earlier compared with noncarriers (p&#x2009;=&#x2009;7.8&#x2009;&#xd7;&#x2009;10-57). Additionally, we identified 197 rare variants (MAF&#x2009;<&#x2009;1%) within ADSP participants not reported in known clinical databases.ConclusionsA small proportion of individuals in the ADSP are carriers of a previously-reported clinically-relevant variant allele for AD and these participants have significantly earlier age of AD onset compared to noncarriers.

Humans